The OPTIMISE Randomized Clinical Trial: Deprescribing Antihypertensive Medications in Adults Aged 80 and Older and its Effect on Blood Pressure
Sheppard J, et al. Effect of Antihypertensive Medication Reduction vs Usual Care on Short-term Blood Pressure Control in Patients with Hypertension Aged 80 Years and
We are very pleased to announce our 2020-2021 cohort of Junior Investigator Intensive Awardees. The Junior Investigator Intensive program provides dedicated supports and research learning
The IMPACT Collaboratory released two new Requests for Applications (RFAs) for conducting pragmatic trials in persons with AD/ADRD on April 20: Request for Applications for
COVID-19 response in post-acute and long-term care: Task force develops new guide to optimize medications.
A task force convened by the Peter Lamy Center on Drug Therapy and Aging at the University of Maryland School of Pharmacy with assistance from
A new review article says it’s time to refine current adverse drug event adjudication methods to fit deprescribing studies.
Ross S, et al. Adverse Drug Events in Older Adults: Review of Adjudication Methods in Deprescribing Studies. J Am Geriatr Soc. 2020; doi: 10.1111/jgs.16382 A
“Potentially” is the key word — the drugs on the list don’t always pose a problem, and no one should stop using any medicine without first checking with a doctor because that could do serious …
Medication overload is an epidemic among older Americans. Every day, 750 Americans age 65 and over are hospitalized for a side effect caused by one
New Clinical Investigation: Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults
Reasons for considering deprescribing cardiovascular medications, by specialty. Goyal P, Anderson TS, et al. Physician Perspectives on Deprescribing Cardiovascular Medications for Older Adults. J Am
The AGING Initiative, an NIH-funded initiative designed to bridge the Health Care Services Research Network and the network of Claude D. Pepper Older Americans Independence